Effect of ischemic preconditioning on hepatic microcirculation and function in a rat model of ischemia reperfusion injury.
Ischemic preconditioning (IPC) may protect the liver from ischemia reperfusion injury by nitric oxide formation. This study has investigated the effect of ischemic preconditioning on hepatic microcirculation (HM), and the relationship between nitric oxide metabolism and HM in preconditioning. Rats were allocated to 5 groups: 1. sham laparotomy; 2. 45 minutes lobar ischemia followed by 2-hour reperfusion (IR); 3. IPC with 5 minutes ischemia and 10 minutes reperfusion before IR; 4. L-arginine before IR; and 5. L-NAME + IPC before IR. HM was monitored by laser Doppler flowmeter. Liver transaminases, adenosine triphosphate, nitrites + nitrates, and guanosine 3'5'-cyclic monophosphate (cGMP) were measured. Nitric oxide synthase (NOS) distribution was studied using nicotinamide adeninine dinucleotide phosphate (NADPH) diaphorase histochemistry. At the end of reperfusion phase, in the IR group, flow in the HM recovered partially to 25.8% of baseline (P < .05 versus sham), whereas IPC improved HM to 49.5% of baseline (P < .01 versus IR). With L-arginine treatment, HM was 31.6% of baseline (NS versus IR), showing no attenuation of liver injury. In the preconditioned group treated with L-NAME, HM declined to 10.2% of baseline, suggesting not only a blockade of the preconditioning effect, but also an exacerbated liver injury. Hepatocellular injury was reduced by IPC, and L-arginine and was increased by NO inhibition with L-NAME. IPC also increased nitrate + nitrate (NOx) and cGMP concentrations. NOS detected by NADPH diaphorase staining was associated with hepatocytes and vascular endothelium, and was induced by IPC. IPC induced NOS and attenuated HM impairment and hepatocellular injury. These data strongly suggest a role for nitric oxide in IPC.
Koti
Rahul S
RS
Hepatic Haemodynamic Unit, University Department of Surgery, Royal Free and University College Medical School, University College London Royal Free Hospital, London, United Kingdom.
Yang
Wenxuan
W
Dashwood
Michael R
MR
Davidson
Brian R
BR
Seifalian
Alexander M
AM
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D006152:Cyclic GMP / Q000378:metabolism; D008058:Dihydrolipoamide Dehydrogenase / Q000378:metabolism; D006439:Hemodynamics / Q000502:physiology; D019194:Ischemic Preconditioning; D008099:Liver / Q000098:blood supply / Q000502:physiology*; D008102:Liver Circulation / Q000502:physiology*; D008833:Microcirculation / Q000502:physiology*; D023421:Models, Animal; D009569:Nitric Oxide / Q000378:metabolism; D051381:Rats; D015427:Reperfusion Injury / Q000503:physiopathology*; D013997:Time Factors
D009569:Nitric Oxide; D000255:Adenosine Triphosphate; D008058:Dihydrolipoamide Dehydrogenase; D006152:Cyclic GMP